Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
International Journal of Cancer|April 28, 2015
S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtypeSidse Ehmsen, Lea Tykgaard Hansen, Martin Bak, et al.
Plos One|May 25, 2012
Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG studyMaria B Lyng, Anne-Vibeke Lænkholm, Rolf Søkilde, et al.
Bioorganic & Medicinal Chemistry|November 5, 2002
A cell-penetrating peptide from a novel pVII-pIX phage-displayed random peptide libraryChangshou Gao, Shenlan Mao, Henrik J Ditzel, et al.
International Journal of Oncology|May 11, 2006
Identification of genes with altered expression in medullary breast cancer vs. ductal breast cancer and normal breast epitheliaMorten F Gjerstorff, Vivian M Benoit, Anne-Vibeke Laenkholm, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|August 30, 2007
Intratumor genetic heterogeneity of breast carcinomas as determined by fine needle aspiration and TaqMan low density arrayMaria B Lyng, Anne-Vibeke Laenkholm, Niels Pallisgaard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor-Positive Metastatic Breast CancerCarla L Alves, Daniel Elias, Maria Lyng, et al.
NPJ Systems Biology and Applications|June 27, 2017
On the performance of de novo pathway enrichmentRicha Batra, Nicolas Alcaraz, Kevin Gitzhofer, et al.
The American Journal of Pathology|June 25, 2004
Molecular analysis of the human autoantibody response to alpha-fodrin in Sjögren's syndrome reveals novel apoptosis-induced specificityToshiaki Maruyama, Ichiro Saito, Yoshio Hayashi, et al.
Plos One|January 24, 2013
Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG studyMaria B Lyng, Anne-Vibeke Lænkholm, Qihua Tan, et al.
Molecular Oncology|April 4, 2014
Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control studyAnnette R Kodahl, Maria B Lyng, Harald Binder, et al.
Pageof 15